(secondQuint)A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients.

 In this open-label pilot study, patients are randomized to 1of the following 4 arms for 24 weeks: Arm 1 (40 patients): DLV plus ZDV plus IDV.

 Arm 2 (40 patients): DLV plus IDV plus 3TC*.

 Arm 3 (40 patients): DLV plus ZDV plus IDV plus 3TC.

 Arm 4 (40 patients): ZDV plus IDV plus 3TC.

 - Dose determined by body weight.

 Patients may opt to continue on study for 24 additional weeks at the discretion of the investigator.

.

 A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients@highlight

The purpose of this study is to see if it is safe and effective to give delavirdine (DLV) in combination with two or three other drugs to HIV-infected patients.

 The drugs to be used in combination with DLV are zidovudine (ZDV), indinavir (IDV), and lamivudine (3TC).

